A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury

Journal of Neurotrauma

Volumn 29, Issue 5, 2012, Pages 865-879

  Domingo, Antoinette ^a   Al Yahya, Abdulaziz A ^c   Asiri, Yousif ^c   Eng, Janice J ^a,b   Lam, Tania ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b GF STRONG REHABILITATION CENTRE   (Canada)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

locomotor function; medication; rehabilitation; spinal cord injury

Indexed keywords

4 AMINOPYRIDINE; BACLOFEN; BROMAZEPAM; CLONIDINE; CYPROHEPTADINE; GANGLIOSIDE GM1; IMIPRAMINE; LEVODOPA; PLACEBO; VALPROATE SEMISODIUM;

APPETITE; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; DRUG SCREENING; DRUG WITHDRAWAL; DRY EYE; FATIGUE; GAIT; HUMAN; HYPOTENSION; LETHARGY; LOCOMOTION; MOTOR ACTIVITY; MUSCLE SPASM; NAUSEA; PARESTHESIA; PHYSIOTHERAPY; RASH; REVIEW; SENSATION; SEXUAL FUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SPINAL CORD INJURY; STRENGTH; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY URGENCY; WALKING; WALKING SPEED; XEROSTOMIA;

GAIT; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; WALKING;

EID: 84858423381     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.2052     Document Type: Review

References (96)

1. Adams, M., and Hicks, A. (2005). Spasticity after spinal cord injury. Spinal Cord 43, 577-586. (Pubitemid 41486865)
2. AHFS Drug Information. 2011. American Society of Health-System Pharmacists, Inc.
3. Anden, N.E., Haeggendal, J., Magnusson, T., and Rosengren, E. (1964). The time course of the disappearance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta Physiol. Scand. 62, 115-118.
4. Anden, N.E., Jukes, M.G., and Lundberg, A. (1966). The effect of DOPA on the spinal cord. 2. A pharmacological analysis. Acta Physiol. Scand. 67, 387-397.
5. Anderson, K.D. (2004). Targeting recovery: priorities of the spinal cord-injured population. J. Neurotrauma 21, 1371-1383. (Pubitemid 39435314)
6. Antri, M., Orsal, D., and Barthe, J.Y. (2002). Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist. Eur. J. Neurosci. 16, 467-476. (Pubitemid 35471865)
7. Azouvi, P., Mane, M., Thiebaut, J.B., Denys, P., Remy-Neris, O., and Bussel, B. (1996). Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch. Phys. Med. Rehabil. 77, 35-39. (Pubitemid 26017489)
8. Baptiste, D.C., and Fehlings, M.G. (2008). Emerging drugs for spinal cord injury. Expert Opin. Emerg. Drugs. 13, 63-80. (Pubitemid 351448703)
9. Barbeau, H., and Rossignol, S. (1991). Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic, serotonergic and dopaminergic drugs. Brain Res. 546, 250-260.
10. Barbeau, H., and Rossignol, S. (1990). The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat. Brain Res. 514, 55-67. (Pubitemid 20147587)
11. Blight, A.R., and Gruner, J.A. (1987). Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats. J. Neurol. Sci. 82, 145-159. (Pubitemid 18001996)
12. Blight, A.R. (1989). Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res. Bull. 22, 47-52.
13. Blight, A.R., Toombs, J.P., Bauer, M.S., and Widmer, W.R. (1991). The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. J. Neurotrauma 8, 103-119.
14. Bracken, M.B., Shepard, M.J., Collins, W.F., Jr., Holford, T.R., Baskin, D.S., Eisenberg, H.M., Flamm, E., Leo-Summers, L., Maroon, J.C., Marshall, L.F., Perot, P.L., Piepmeier, J., Sonntag, V.K., Wagner, F.C., Wilberger, J.L., Winn, H.R., and Young, W. (1992). Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J. Neuro-surg. 76, 23-31.
15. Bracken, M.B., Shepard, M.J., Holford, T.R., Leo-Summers, L., Aldrich, E.F., Fazl, M., Fehlings, M.G., Herr, D.L., Hitchon, P.W., Marshall, L.F., Nockels, R.P., Pascale, V., Perot, P.L., Jr., Piepmeier, J., Sonntag, V.K., Wagner, F., Wilberger, J.E., Winn, H.R., and Young, W. (1998). Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J. Neurosurg. 89, 699-706. (Pubitemid 28485526)
16. Brown, T.G. (1911). The intrinsic factors in the act of progression in the mammal. Proc. R. Soc. Lond. B. Biol. Sci. 84, 308-319.
17. Brustein, E., and Rossignol, S. (1999). Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. II. Effects of noradrenergic and serotoninergic drugs. J. Neuro-physiol. 81, 1513-1530. (Pubitemid 29262484)
18. Calancie, B., Needham-Shropshire, B., Jacobs, P., Willer, K., Zych, G., and Green, B.A. (1994). Involuntary stepping after chronic spinal cord injury. Evidence for a central rhythm generator for locomotion in man. Brain 117 (Pt. 5), 1143-1159. (Pubitemid 24350546)
19. Carlson, K.D., and Schmidt, F.L. (1999). Impact of experimental design on effect size: Findings from the research literature on training. J. Appl. Psychol. 84, 851-862.
20. Carlsson, A., Magnusson, T., and Rosengren, E. (1963). 5-Hydroxytryptamine of the spinal cord normally and after transection. Experientia 19, 359.
21. Carp, J.S., and Rymer, W.Z. (1986). Enhancement by serotonin of tonic vibration and stretch reflexes in the decerebrate cat. Exp. Brain Res. 62, 111-122. (Pubitemid 16162067)
22. Chau, C., Barbeau, H., and Rossignol, S. (1998a). Early loco-motor training with clonidine in spinal cats. J. Neurophysiol. 79, 392-409. (Pubitemid 28133830)
23. Chau, C., Barbeau, H., and Rossignol, S. (1998b). Effects of in-trathecal alpha1-and alpha2-noradrenergic agonists and norepinephrine on locomotion in chronic spinal cats. J. Neurophysiol. 79, 2941-2963. (Pubitemid 28317025)
24. Cohen, J. (1977). Statistical Power Analysis for the Behavioral Sciences. Academic Press: New York.
25. Commissiong, J.W. (1985). The synthesis and metabolism of catecholamines in the spinal cord of the rat after acute and chronic transections. Brain Res. 347, 104-111. (Pubitemid 16228668)
26. Courtine, G., Gerasimenko, Y., van den Brand, R., Yew, A., Musienko, P., Zhong, H., Song, B., Ao, Y., Ichiyama, R.M., Lavrov, I., Roy, R.R., Sofroniew, M.V., and Edgerton, V.R. (2009). Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat. Neurosci. 12, 1333-1342.
27. Cripps, R.A., Lee, B.B., Wing, P., Weerts, E., Mackay, J., and Brown, D. (2010). A global map for traumatic spinal cord injury epidemiology: towards a living data repository for injury prevention. Spinal Cord 49, 493-501.
28. DeForge, D., Nymark, J., Lemaire, E., Gardner, S., Hunt, M., Martel, L., Curran, D., and Barbeau, H. (2004). Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial. Spinal Cord 42, 674-685. (Pubitemid 40065531)
29. Devilly, G.J. (2004). The Effect Size Generator for Windows. Centre for Neuropsychology: Swinburne University, Australia.
30. Dimitrijevic, M.R., Gerasimenko, Y., and Pinter, M.M. (1998). Evidence for a spinal central pattern generator in humans. Ann. NY Acad. Sci. 860, 360-376. (Pubitemid 29045983)
31. Ditunno, P., Patrick, M., Stineman, M., and Ditunno, J.F. (2008). Who wants to walk? Preferences for recovery after SCI: a longitudinal and cross-sectional study. Spinal Cord 46, 500-506. (Pubitemid 351948243)
32. Donnelly, C., Eng, J.J., Hall, J., Alford, L., Giachino, R., Norton, K., and Kerr, D.S. (2004). Client-centred assessment and the identification of meaningful treatment goals for individuals with a spinal cord injury. Spinal Cord 42, 302-307. (Pubitemid 38903493)
33. Downs, S.H., and Black, N. (1998). The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 52, 377-384. (Pubitemid 28438523)
34. Edgerton, V.R., and Roy, R.R. (2009). Robotic training and spinal cord plasticity. Brain Res. Bull. 78, 4-12.
35. Elbasiouny, S.M., Moroz, D., Bakr, M.M., and Mushahwar, V.K. (2010). Management of spasticity after spinal cord injury: current techniques and future directions. Neurorehabil. Neural Repair 24, 23-33.
36. Eng, J.J., Teasell, R., Miller, W.C., Wolfe, D.L., Townson, A.F., Aubut, J.-A., Abramson, C., Hsieh, J., and Connolly, S. (2007). SCIRE: Spinal Cord Injury Rehabilitation Evidence, Chapter 2: Methods of Systematic Reviews. ICORD: Vancouver.
37. Estores, I.M. (2003). The consumer's perspective and the professional literature: what do persons with spinal cord injury want? J. Rehabil. Res. Develop. 40, 93-98. (Pubitemid 36988684)
38. Feraboli-Lohnherr, D., Barthe, J.Y., and Orsal, D. (1999). Serotonin-induced activation of the network for locomotion in adult spinal rats. J. Neurosci. Res. 55, 87-98. (Pubitemid 29014414)
39. Field-Fote, E.C., and Roach, K.E. (2011). Influence of a locomotor training approach on walking speed and distance in people with chronic spinal cord injury: a randomized clinical trial. Phys. Ther. 91, 48-60.
40. Foley, N.C., Teasell, R.W., Bhogal, S.K., and Speechley, M.R. (2003). Stroke rehabilitation evidence-based review: methodology. Top Stroke Rehabil. 10, 1-7. (Pubitemid 36576989)
41. Fong, A.J., Cai, L.L., Otoshi, C.K., Reinkensmeyer, D.J., Burdick, J.W., Roy, R.R., and Edgerton, V.R. (2005). Spinal cord-transected mice learn to step in response to quipazine treatment and robotic training. J. Neurosci. 25, 11738-11747. (Pubitemid 43098466)
42. Forssberg, H., and Grillner, S. (1973). The locomotion of the acute spinal cat injected with clonidine i.v. Brain Res. 50, 184-186.
43. Fung, J., Stewart, J.E., and Barbeau, H. (1990). The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects. J. Neurol. Sci. 100, 85-93.
44. Geisler, F.H., Coleman, W.P., Grieco, G., and Poonian, D. (2001). The Sygen multicenter acute spinal cord injury study. Spine 26, S87-S98.
45. Gorassini, M.A., Norton, J.A., Nevett-Duchcherer, J., Roy, F.D., and Yang, J. (2009). Changes in locomotor muscle activity after treadmill training in subjects with incomplete spinal cord injury. J. Neurophysiol. 101, 969-979.
46. Grillner, S., and Zangger, P. (1979). On the central generation of locomotion in the low spinal cat. Exp. Brain Res. 34, 241-261. (Pubitemid 9249372)
47. Guertin, P.A., and Brochu, C. (2009). Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient. Spinal Cord 47, 91-92.
48. Guertin, P.A., Ung, R.V., and Rouleau, P. (2010). Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy. Biotechnol. J. 5, 421-426.
49. Guest, J.D., Hiester, E.D., and Bunge, R.P. (2005). Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192, 384-393. (Pubitemid 40341683)
50. Harkema, S.J. (2001). Neural plasticity after human spinal cord injury: application of locomotor training to the rehabilitation of walking. Neuroscientist 7, 455-468. (Pubitemid 32923760)
51. Hicks, A., and Ginis, K.A. (2008). Treadmill training after spinal cord injury: it's not just about the walking. J. Rehabil. Res. Develop. 45, 241-248.
52. Ichiyama, R.M., Courtine, G., Gerasimenko, Y.P., Yang, G.J., van den Brand, R., Lavrov, I.A., Zhong, H., Roy, R.R., and Edgerton, V.R. (2008). Step training reinforces specific spinal loco-motor circuitry in adult spinal rats. J. Neurosci. 28, 7370-7375.
53. Iles, J.F., and Roberts, R.C. (1986). Presynaptic inhibition of monosynaptic reflexes in the lower limbs of subjects with upper motoneuron disease. J. Neurol. Neurosurg. Psychiatry 49, 937-944. (Pubitemid 16048424)
54. Jankowska, E., Jukes, M.G., Lund, S., and Lundberg, A. (1967b). The effect of DOPA on the spinal cord. 6. Half-centre organization of interneurones transmitting effects from the flexor reflex afferents. Acta Physiol. Scand. 70, 389-402.
55. Jankowska, E., Jukes, M.G., Lund, S., and Lundberg, A. (1967a). The effect of DOPA on the spinal cord. 5. Reciprocal organization of pathways transmitting excitatory action to alpha motoneur-ones of flexors and extensors. Acta Physiol. Scand. 70, 369-388.
56. Keirstead, H.S., Nistor, G., Bernal, G., Totoiu, M., Cloutier, F., Sharp, K., and Steward, O. (2005). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants re-myelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694-4705. (Pubitemid 40664118)
57. Krassioukov, A., and Claydon, V.E. (2006). The clinical problems in cardiovascular control following spinal cord injury: an overview. Prog. Brain Res. 152, 223-229.
58. Kwon, B.K., Okon, E.B., Plunet, W., Baptiste, D., Fouad, K., Hillyer, J., Weaver, L.C., Fehlings, M.G., and Tetzlaff, W. (2011a). A systematic review of directly applied biologic therapies for acute spinal cord injury. J. Neurotrauma 28, 1589-1610.
59. Kwon, B.K., Okon, E., Hillyer, J., Mann, C., Baptiste, D., Weaver, L.C., Fehlings, M.G., and Tetzlaff, W. (2011b). A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J. Neurotrauma 28, 1545-1588.
60. Lam, T., Noonan, V., Eng, J., and Team, S.R. (2008). A systematic review of functional ambulation outcome measures in spinal cord injury. Spinal Cord 46, 246-254. (Pubitemid 351498868)
61. Levi, R., Hultling, C., and Seiger, A. (1995). The Stockholm Spinal Cord Injury Study: 2. Associations between clinical patient characteristics and post-acute medical problems. Paraplegia 33, 585-594.
62. Li, Y., Li, X., Harvey, P.J., and Bennett, D.J. (2004). Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity. J. Neuro-physiol. 92, 2694-2703. (Pubitemid 40340482)
63. Lipsey, M.W., and Wilson, D.B. (1993). The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. Am. Psychol. 48, 1181-1209.
64. Lundqvist, C., Siosteen, A., Blomstrand, C., Lind, B., and Sullivan, M. (1991). Spinal cord injuries. Clinical, functional, and emotional status. Spine (Phila. Pa. 1976) 16, 78-83.
65. Maric, O., Zorner, B., and Dietz, V. (2008). Levodopa therapy in incomplete spinal cord injury. J. Neurotrauma 25, 1303-1307.
66. Marley, E., and Vane, J.R. (1967). Tryptamines and spinal cord reflexes in cats. Br. J. Pharmacol. Chemother. 31, 447-465.
67. McDonald, J.W., and Belegu, V. (2006). Demyelination and re-myelination after spinal cord injury. J. Neurotrauma 23, 345-359. (Pubitemid 43726315)
68. Mehrholz, J., Kugler, J., and Pohl, M. (2008). Locomotor training for walking after spinal cord injury. Cochrane Database Syst. Rev. (Online).CD006676.
69. Mocchetti, I. (2005). Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol. Life Sci. 62, 2283-2294. (Pubitemid 41500544)
70. Moseley, A.M., Herbert, R.D., Sherrington, C., and Maher, C.G. (2002). Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro). Aust. J. Physi-other. 48, 43-49. (Pubitemid 34240086)
71. Nashmi, R., and Fehlings, M.G. (2001). Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res. Brain Res. Rev. 38, 165-191. (Pubitemid 34066501)
72. National Spinal Cord Injury Statistical Center. (2006). Facts and figures at a glance. Birmingham, AL.
73. Nistor, G.I., Totoiu, M.O., Haque, N., Carpenter, M.K., and Keirstead, H.S. (2005). Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49, 385-396. (Pubitemid 40222916)
74. Noreau, L., Proulx, P., Gagnon, L., Drolet, M., and Laramee, M.T. (2000). Secondary impairments after spinal cord injury: a population-based study. Am. J. Phys. Med. Rehabil. 79, 526-535.
75. Norman, K.E., Pépin, A., and Barbeau, H. (1998). Effects of drugs on walking after spinal cord injury. Spinal Cord 36, 699-715. (Pubitemid 28479076)
76. Pearlstein, E., Ben Mabrouk, F., Pflieger, J.F., and Vinay, L. (2005). Serotonin refines the locomotor-related alternations in the in vitro neonatal rat spinal cord. Eur. J. Neurosci. 21, 1338-1346. (Pubitemid 40516632)
77. Rank, M.M., Li, X., Bennett, D.J., and Gorassini, M.A. (2007). Role of endogenous release of norepinephrine in muscle spasms after chronic spinal cord injury. J. Neurophysiol. 97, 3166-3180. (Pubitemid 47084735)
78. Rémy-Néris, O., Barbeau, H., Daniel, O., Boiteau, F., and Bussel, B. (1999). Effects of intrathecal clonidine injection on spinal reflexes and human locomotion in incomplete paraplegic subjects. Experimental Brain Research Experimentelle Hirn-forschung Expérimentation cérébrale 129, 433-440. (Pubitemid 29537614)
79. Reubinoff, B.E., Itsykson, P., Turetsky, T., Pera, M.F., Reinhartz, E., Itzik, A., and Ben-Hur, T. (2001). Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19, 1134-1140. (Pubitemid 33115699)
80. Rossignol, S., Giroux, N., Chau, C., Marcoux, J., Brustein, E., and Reader, T.A. (2001). Pharmacological aids to locomotor training after spinal injury in the cat. J. Physiol. 533, 65-74. (Pubitemid 32499358)
81. Sackett, D.L., Straus, S.E., Richardson, W.S., Rosenberg, W., and Haynes, R.B. (2000). Evidence-Based Medicine: How to Practice and Teach EBM. Churchill Livingstone: Toronto, ON.
82. Scheidtmann, K., Fries, W., Muller, F., and Koenig, E. (2001). Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358, 787-790. (Pubitemid 32868727)
83. Segal, J.L., and Brunnemann, S.R. (1998). 4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humans. J. Spinal Cord Med. 21, 200-204. (Pubitemid 128735588)
84. Sherratt, R.M., Bostock, H., and Sears, T.A. (1980). Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature 283, 570-572. (Pubitemid 10136031)
85. Smith, K.J., Felts, P.A., and John, G.R. (2000). Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. Brain 123 (Pt. 1), 171-184. (Pubitemid 30037979)
86. Steeves, J.D., Lammertse, D., Curt, A., Fawcett, J.W., Tuszynski, M.H., Ditunno, J.F., Ellaway, P.H., Fehlings, M.G., Guest, J.D., Kleitman, N., Bartlett, P.F., Blight, A.R., Dietz, V., Dobkin, B.H., Grossman, R., Short, D., Nakamura, M., Coleman, W.P., Gaviria, M., and Privat, A. (2007). Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 45, 206-221. (Pubitemid 46340849)
87. Stewart, J.E., Barbeau, H., and Gauthier, S. (1991). Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients. Can. J. Neurol. Sci. 18, 321-332.
88. Taricco, M., Adone, R., Pagliacci, C., and Telaro, E. (2000). Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst. Rev.CD001131.
89. Tetzlaff, W., Okon, E.B., Karimi-Abdolrezaee, S., Hill, C.E., Sparling, J.S., Plemel, J.R., Plunet, W.T., Tsai, E.C., Baptiste, D., Smithson, L.J., Kawaja, M.D., Fehlings, M.G., and Kwon, B.K. (2011). A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28, 1611-1682.
90. van der Bruggen, M.A., Huisman, H.B., Beckerman, H., Bertelsmann, F.W., Polman, C.H., and Lankhorst, G.J. (2001). Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury. J. Neurol. 248, 665-671. (Pubitemid 32695862)
91. Wainberg, M., Barbeau, H., and Gauthier, S. (1990). The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J. Neurol. Neurosurg. Psychiatr. 53, 754-763. (Pubitemid 20296517)
92. Walker, J.B., and Harris, M. (1993). GM-1 ganglioside administration combined with physical therapy restores ambulation in humans with chronic spinal cord injury. Neurosci. Lett. 161, 174-178. (Pubitemid 23314861)
93. Waxman, S.G. (1989). Demyelination in spinal cord injury. J. Neurol. Sci. 91, 1-14. (Pubitemid 19161689)
94. Winchester, P., Smith, P., Foreman, N., Mosby, J.M., Pacheco, F., Querry, R., and Tansey, K. (2009). A prediction model for determining over ground walking speed after locomotor training in persons with motor incomplete spinal cord injury. J. Spinal Cord Med. 32, 63-71.
95. Wirz, M., Zemon, D.H., Rupp, R., Scheel, A., Colombo, G., Dietz, V., and Hornby, T.G. (2005). Effectiveness of automated lo-comotor training in patients with chronic incomplete spinal cord injury: a multicenter trial. Arch. Phys. Med. Rehabil. 86, 672-680. (Pubitemid 40487831)
96. Wu, B., and Ren, X. (2009). Promoting axonal myelination for improving neurological recovery in spinal cord injury. J. Neurotrauma 26, 1847-1856.